Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
Rx sales of adult incontinence continued to show consistent growth in Kazakhstan in 2022 and unlike retail adult incontinence was not affected to the same extent by inflation caused by the energy crisis stemming from the war in Ukraine. An ageing…
Rx/reimbursement adult incontinence declined in volume sales for a further year in 2022. As the Dutch government tried to reduce high spiralling costs in health care, rules and regulations surrounding health care services became more restrictive.…
There have been rises in unit prices during 2022, the consequence of higher energy costs, material costs, and labour and shipping costs, leading manufacturers to increase unit prices. As such, value sales have recorded double-digit growth for the…
The distribution of RX/reimbursement adult incontinence varies depending on the region in Italy, given that each region is entitled to establish its own rules. In general, consumers can collect products at pharmacies, or they can receive parcels…
Rx/reimbursement adult incontinence continues its slightly increasing trend in 2022, which is as per the norm for the essential nature of the category. There was a small deceleration in the first year of the COVID-19 pandemic in 2020, as consumers…
Since 1984 the Spanish public health system has included adult incontinence protection in the list of medical products which can be purchased on e-commerce and via health and beauty specialists with the possibility of later reimbursement. In 2022,…
Rx/reimbursement adult incontinence posted further positive value and volume sales growth in 2022, although the latter was slower compared to the previous year. This was due to the lower volume distribution of these products as part of government…
The National Insurance Institute of Israel encourages the elderly to remain at home in their communities. For this reason, it grants long-term care benefits to those who choose to stay at home. Funds are provided for seniors who meet specific…
Rx/reimbursement products demonstrated robust volume growth in 2022 fuelled in part by rising awareness of the reimbursement system. Only moderate/heavy incontinence products (excluding pads) are reimbursed by the government for medical conditions.…
Despite many Swiss consumers visiting their doctors more frequently attempting to save some money by obtaining prescriptions for incontinence products volume and value sales of Rx/reimbursement adult incontinence declined marginally. The rapid…
In 2022, Rx/reimbursement adult incontinence registered moderate volume growth, though value total value sales continued to be low, as funding through Rx channels in limited. That being said, an ageing population contributed to the continued volume…
Demand increased during 2022, with a couple of key drivers behind this growth. Firstly, the country's ageing population continued to drive ongoing demand for RX/reimbursement adult incontinence. In addition, the demand for reimbursement for adult…
PAMI (the National Institute of Social Services for Retirees and Pensioners) is the public institution charged with providing healthcare coverage to elderly people in Argentina, a remit that includes the distribution of Rx/reimbursement adult…
The Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022 changed who can get payments under the Continence Aids Payment Scheme (CAPS) to avoid double-dipping. It means that care recipients who already receive continence products as…
High inflation in 2022 meant that Rx/reimbursement retail adult incontinence in Norway saw a pronounced spike in unit prices, leading to double-digit current value growth. Despite this, the category continued to enjoy solid and robust volume growth.…
Sales of Rx adult incontinence performed well in 2022 benefiting from a change in legislation in 2021. The new legislation brought in a higher monthly quota for heavy adult incontinence products, enabling patients to receive 60 units per month…
In 2022, Rx/reimbursement adult incontinence registered moderate volume growth, though value total value sales continued to be low, as funding through Rx channels in limited. Moderate/heavy adult incontinence products performed better than light, as…
Heightened health awareness, an expanding incontinence consumer base, as well as pandemic-induced rising enrolment in Medicaid, a critical safety net for a vast vulnerable population in the US during economic downturns, continued to drive sales of…
Incontinence products are available on prescription in Croatia for those who have severe incontinence problems which have been diagnosed by a doctor. Therefore, the majority of adult incontinence products sold in Croatia fall under Rx/reimbursement…
Demand for Rx/reimbursement adult incontinence is growing. Aside from the ageing of the population, there is a growing awareness of this particular health problem. Large social campaigns are visible across all media, including television and the…